Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease
-
Published:2023-04
Issue:4
Volume:78
Page:693-703
-
ISSN:0168-8278
-
Container-title:Journal of Hepatology
-
language:en
-
Short-container-title:Journal of Hepatology
Author:
Sanyal Arun J., Williams Stephen A.ORCID, Lavine Joel E.ORCID, Neuschwander-Tetri Brent A.ORCID, Alexander LeighORCID, Ostroff RachelORCID, Biegel HannahORCID, Kowdley Kris V., Chalasani NagaORCID, Dasarathy SrinivasanORCID, Diehl Anna Mae, Loomba Rohit, Hameed Bilal, Behling Cynthia, Kleiner David E., Karpen Saul J., Williams Jessica, Jia Yi, Yates Katherine P.ORCID, Tonascia James
Reference30 articles.
1. Global Perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis;Younossi;Hepatology (Baltimore, Md),2019 2. Association of histologic disease activity with progression of nonalcoholic fatty liver disease;Kleiner;JAMA Netw open,2019 3. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease;Estes;Hepatology (Baltimore, Md),2018 4. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030;Estes;J Hepatol,2018 5. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|